
Reflections on Medicaid: Balancing Compassion, Responsibility, and Neurosurgical Autonomy
As physicians, compassion and dedication toward our patients define the core of our professional mission. Providing high-quality neurosurgical care to everyone who needs it remains our unwavering commitment. Yet, alongside this dedication, we have an equally important responsibility: to safeguard our own family’s financial security and personal well-being. Ensuring appropriate compensation is therefore essential—not merely as self-interest, but as a critical foundation for sustainable patient care.
The issue of Medicaid reform requires thoughtful advocacy. It is essential that we, as neurosurgeons, engage proactively to ensure policies reflect the complexity, resource intensity, and value of neurosurgical services. Medicaid reimbursement must be set responsibly to maintain access to specialized neurological care without compromising our professional independence.
While supporting responsible budgetary measures and value-based initiatives that incentivize quality outcomes, we must remain cautious of healthcare models—such as HMOs or overly restrictive managed-care arrangements—that diminish neurosurgeon autonomy and limit our ability to deliver individualized patient care. True patient-centered care depends fundamentally upon preserving our clinical decision-making independence.
To that end, I encourage all of us to actively engage with policymakers, advocating for reforms that support collaborative care models without sacrificing physician autonomy. By participating directly in policy discussions, we ensure that neurosurgery’s unique perspective is considered, protecting both our patients and our specialty.
Additionally, advocating for investments in workforce development through funding for neurosurgical residency positions and continuous medical education remains crucial. These initiatives strengthen our specialty, ensuring sustainable, independent neurosurgical practices capable of meeting patient needs throughout California.
In summary, as we navigate ongoing Medicaid reform efforts, our unified advocacy should center on maintaining fair compensation, protecting neurosurgical autonomy, and enhancing patient care through responsible, balanced policies.
Thank you for your continued commitment to excellence in neurosurgery.
Best regards,
Sam Ghostine, MD
President, California Association of Neurological Surgeons (CANS)
Editor’s Note: The pieces in this month’s issue are based on a robust internal policy discussion among CANS members. These represent various views from members within the organization and not of CANS itself. We hope this invites continued dialogue on how best to sustain access and fiscal responsibility in public health coverage.

On Thursday, May 22, 2025 HR 1, the President’s “Big Beautiful Bill,” passed the U.S. House of Representatives by a narrow 215-214 vote. It now moves to the Senate where we can anticipate more changes to be made.
This summary of provisions below was largely taken from the Kaiser Family Foundation website. Please read to the end for my comments.
Brief Bill Summary:
Medicaid Impact
Congressional Budget Office (CBO) estimates:
Medicaid Provisions
Affordable Care Act Provisions
Medicare Physician Payment
Potential Medicare Sequestration Cuts Triggering Physician Payment Cuts
Student Loan Provisions for New Loans After 2026
Health Savings Accounts
Pharmacy Benefit Manager (PBM) Reform and Medicare Drug Price Negotiation
Now I don’t disagree with everything is this bill. I understand that there may be aspects of fiscal containment that are necessary in the above provisions. However, what worries me is that saving money may come at a tremendous cost. And many of the cost savings are short-sighted and will only serve to increase overall health care costs for everyone.
A recent publication from the non-partisan National Bureau of Economic Research, looked at 37 million low-income adults who gained Medicaid coverage in states that expanded the program under the ACA. What they found was that these people were 21 % less likely to die in a given year of enrollment than those who did not gain coverage. States that expanded Medicaid saved 27, 400 lives between 2010 and 2022 and states that did not missed the opportunity to save 12,800 more lives. (editors note, for a critical analysis of the article please click here)
Another recent study in NEJM looked at the dual population of Medicare and Medicaid eligible people. These, roughly 12 million Americans have the unfortunate problem that when they lose their Medicaid they also lose their Medicare coverage that lowers prescription drug costs by approximately $6000/year. For those who lost this subsidy, it was found that they:
-filled 1.2 fewer prescriptions on average
-were between 4% and 22% more likely to die depending on their level of co-morbidities
-were most likely to die during the 17-month study period if they had high drug costs and were more likely to die if they had HIV, cardiovascular or pulmonary diseases. This paper suggests that by improving access to medications, Medicaid can improve patient survival. This population will also be the most vulnerable if they even temporarily lose coverage due to the above policies that will likely increase “churn” by increasing the administrative burden.
As a neurosurgeon, this issue of reducing access is no more obvious than in our emergency rooms. Due to the federal law, EMTALA, and our ethical principles as physicians, we are obligated to provide emergency care to everyone who walks through those doors. If a larger proportion of those patients are uninsured, which will happen if Medicaid eligibility is further limited, than the hospitals and physicians will have to absorb this uncompensated care. In rural communities, it is projected that this will lead to increasing ER and hospital closures leading to large geographic gaps in care, especially in sub-specialties like ours. Furthermore, fewer neurosurgeon practices will be able to afford to cover on-call care in ERs if they are not getting reimbursed for a higher proportion of patients they see. That means the insured patients in these communities will also have decreased access to physicians and services.
Arguments will be made that creating a leaner, meaner Medicaid will improve care and lead to more patients entering the commercial market, but I don’t see the straight line that leads from these cuts to this outcome? Why would insurance companies charge less and take on more medically and socioeconomically disadvantaged patients? The main population of adults affected by the ACA expansion only make $21,000/year. They cannot afford private insurance. This legislation allows the ACA tax credits to expire so they cannot take advantage of those credits to try to afford ACA coverage. There is nowhere for them to go, except to be uninsured. We all would like to see less patients that need Medicaid but that is a societal problem that these cuts won’t address but only exacerbate.
In summary, this bill really doesn’t attempt to make Medicaid more efficient. This is about coming up with cuts to fund the President’s other priorities. Where is the plan to truly reform the Medicaid program, such as more coordinated care for dual eligibles which would provide higher quality care and save significant money? While fraud and abuse exist and this absolutely should be addressed, the impact of this on overall cost has been shown to be relatively minor. Furthermore, let us not celebrate a Medicare “fix” to our reimbursement that gets us back to what we were paid in 2024 by 2029 when we all have felt the pain of inflation. This bill does not serve doctors or patients, and we should not accept being on the budgetary chopping block…again.

Graphic of the Month:
This month’s graphic shows that even under the proposed Medicaid “cuts,” total spending will continue to grow. The changes simply aim to slow the rate of growth and do not reduce overall funding. It’s a reminder that in government budgeting, a “cut” often means still spending more than last year, just at a slower pace.

CANS MISSION STATEMENT
To Advocate for the Practice of California Neurosurgery
Benefitting our Patients and Profession
The California Association of Neurological Surgeons would like to thank all of exhibitors in helping making our annual meeting a success!
We value your presence and hope to have you all next year in Southern California!
Medtronic -Gold Sponsor
Aesculap – Silver Sponsor
Cooperative of American Physicians -Silver Sponsor
Integra LifeSciences-Silver Sponsor
Orthofix -Silver Sponsor
Rosman Search -Silver Sponsor
Surgeons Capitol Management -Silver Sponsor
Ruthless Spine -Board Meeting Presentation
Astura Medical
ATEC Spine
Brainlab, Inc
Carbofix Spine
Cerspedics
Day Surgical Products, Inc
GE Healthcare
Globus
GT Medtech
Johnson & Johnson Medtech
KLS Martin
Leica Microsystems
META Dynamic, Inc
Mitaka USA, Inc
NX Development Corp
Q Surgical
Spineart
Stryker Spine
Surgical Theater
Zap Surgical

What Every Graduating Neurosurgeon Should Know
As another academic year draws to a close, I want to begin by honoring this year’s graduating neurosurgery residents. Your dedication, resilience, and countless hours in the operating room and at the bedside inspire us all. The knowledge, mentorship, and camaraderie you’ve shared have shaped our programs and set a standard for those who follow. As you step forward into practice, you carry not only your own achievements but the hopes and gratitude of your co-residents, colleagues and patients alike.
With that in mind, I’d like to share some reflections on a challenge that will soon be at the forefront of your careers: the rapidly evolving landscape of Medicaid policy. While these debates may seem distant amid the intensity of clinical work, the reality is that Medicaid reform will shape our daily practice and the care we provide for years to come.
Congress is currently considering major changes to Medicaid, including stricter eligibility verification, new work requirements, and significant funding cuts. While these proposals are framed as necessary cost-saving measures, many experts—and our own mentors—warn that millions of Americans, especially the most vulnerable (including a majority of our patients), could lose coverage not because they’re ineligible, but due to administrative hurdles. From a neurosurgical perspective, Medicaid is a critical payer for patients who require complex, ongoing care, from young trauma victims to elderly patients needing long-term support.
The proposed reforms are expected to hit elderly patients particularly hard. Over seven million Americans over 65 depend on Medicaid for nursing home stays and essential home-based services post-hospitalization. If funding is cut, states may be forced to limit these services, increase waiting lists, or reduce provider payments. This could leave many seniors with fewer choices and higher out-of-pocket expenses – with longer inpatient length of stays pending dispositions. For us, this may mean seeing more elderly patients presenting with advanced, preventable complications, and families struggling to access rehabilitation or post-acute care.
The financial strain won’t stop at the patient level. Safety-net hospitals, where many of us have trained, could face reduced resources and staffing as they absorb more uncompensated care. Administrative burdens will likely increase as well, with more time spent helping patients navigate insurance lapses and eligibility requirements. These challenges threaten not only patient outcomes but also professional satisfaction and the sustainability of our practices.
As you transition into independent practice, staying informed about Medicaid policy—both federally and at the state level—will be essential. Collaborating with your institution’s social workers and case managers to help patients maintain coverage will become part of daily life. And while advocacy may seem daunting, remember that our voices, especially when joined with those of our mentors and colleagues, can influence policy and protect patient access.
Ultimately, Medicaid reform in 2025 is not just a policy issue; it’s a defining challenge for neurosurgeons at every stage of their careers. As you take this next step, and as I prepare to follow in your footsteps, let’s remain engaged, adaptable, and committed to the values that unite our specialty. The future of neurosurgical care—and the well-being of our most vulnerable patients—will depend on our collaboration and resolve.

Neurosurgical Economics
Rethinking Medicaid: Sustainability, Access, and First Principles
The “big beautiful bill” that passed the U.S. House includes substantial reforms to Medicaid, reforms that have generated strong reactions across the political and policy spectrum. But instead of framing the discussion in partisan terms, it’s worth asking a more foundational question: What should Medicaid be?
Medicaid was designed as a safety-net program, intended to serve the disabled, low-income pregnant women, the elderly poor, and children. Over time, especially following the ACA’s expansion, Medicaid has grown far beyond its original scope. Today, Medi-Cal covers over 40% of Californians. This a scale far beyond what most safety-net programs are built to handle sustainably.
Because of Medicaid’s unique financing structure, where the federal government reimburses states for a large portion of their spending (90% for ACA expansion enrollees, and less for traditional populations), and because provider taxes can draw down even more federal funds, states face little pressure to control enrollment. The result: nearly 90% of Medi-Cal’s funding is now federally subsidized. Meanwhile, Managed Care Organizations (MCOs) are paid per-member-per-month, regardless of whether the patient uses services. That means the system spends money even when beneficiaries don’t realize they’re enrolled.
The House bill proposes a set of commonsense eligibility verifications: ensuring patients aren’t enrolled in multiple states, are alive, aren’t sitting on substantial assets, and meet residency or citizenship requirements. These checks are standard in most public benefit programs and even California’s governor has voiced support for more accurate eligibility targeting. The procedural checks are not onerous, and verifying address, income, or citizenship status is standard across safety-net programs. Importantly, Medicaid Managed Care Organizations (MCOs) are financially incentivized to help eligible enrollees maintain coverage. If someone is eligible, they have every reason to remain enrolled.
The bill also introduces a modest community engagement requirement for able-bodied adults without dependents: 20 hours per week of work, school, training, or community service. It includes numerous exemptions for pregnant women, caregivers, elderly, and the medically frail. This isn’t punitive. It reflects evidence that workforce participation correlates with better long-term health outcomes and improves program integrity. Furthermore, it incentivizes MCOs to create job assistance programs so beneficiaries can maintain coverage while the MCOs continue to receive payment. For those who emphasize social determinants of health, this is a win-win: private actors helping Medicaid beneficiaries find work and stay insured.
Importantly, this bill would save over $800 billion over the next decade, largely by returning Medicaid to its pre-COVID growth trajectory. These savings would help fund a long-overdue fix to Medicare physician payment by tying it to the Medicare Economic Index (MEI). That change alone is a major win for physicians and their patients, especially those who rely on timely access to Medicare-funded care.
Some argue that any reduction in Medicaid enrollment is inherently bad. I disagree. Losing coverage because you no longer meet the criteria for a safety-net program is not a failure. A leaner, more focused Medicaid is not a retreat from compassion. It’s a recommitment to integrity and sustainability.
It’s a large logical leap to suggest that a significant number of citizens will become uninsured as a result of this bill. While the CBO projects reduced enrollment, those projections often conflate procedural disenrollments with actual loss of access. The most likely group to lose coverage entirely is undocumented immigrants, individuals whom California has chosen to allow here by adopting a sanctuary status, in violation of Federal law. HR1 simply removes the expectation that federal taxpayers should subsidize that decision.
California is free to set its own priorities, including sanctuary policies or coverage for non-citizens. But it must also be willing to fund those priorities independently. If state leaders are concerned about the cost burden this places on physicians and hospitals, they can create a state-level uncompensated care fund or offer tax relief for providers. Alternatively, physicians concerned about this issue should advocate for reforming California’s sanctuary status to better align with federal immigration and eligibility standards.
None of this is to suggest we abandon compassion or emergency care. Rather, it’s a call for fiscal responsibility and honest federalism. If California wants to lead on expanded access, it should also lead on financing it.
Ultimately, we should work to fix the commercial market, so that working-age adults can afford private coverage and ensure that Medicaid remains viable for the vulnerable populations it was designed to serve.
CANS, Annual Meeting
January 16-18, 2026 Oxnard, CA
CSNS Meeting April 24-25 Boston, MA
Any CANS member who is looking for a new associate/partner/PA/NP or who is looking for a position (all California neurosurgery residents are CANS members and get this newsletter) is free to submit a 150 word summary of a position available or of one’s qualifications for a two month posting in this newsletter. Submit your text to the CANS editorial office by emailing Anthony.digiorgio@ucsf.edu
Newsletter Editor
Anthony DiGiorgio, D.O.
Contributing Editors
Deborah C. Henry, M.D.
Brian Gantwerker, M.D.
Ian Ross, M.D.
This newsletter is published monthly from the Executive Office:
California Association of
Neurological Surgeons
5380 Elvas Avenue
Suite 215
Sacramento, CA 95819
Tel 916 457-2267
Fax 916 457-8202
www.cans1.org
CANS Board of Directors
| President | Samer Ghostine, MD | Los Angeles |
| President-Elect | Brian Gantwerker, MD | Santa Monica |
| Vice-Pres | Anthony DiGiorgio, DO | San Francisco |
| Secretary | Odette Harris, MD | Stanford |
| Treasurer | Sanjay Dhall, MD | Los Angeles |
| Imd Past Pres | Ciara Harraher, MD | Santa Cruz |
| Past President | Joseph Chen, MD | Bakersfield |
Directors — Northern CA
| Marco Lee, MD | Stanford |
| Eze Goldschmidt, MD | San Francisco |
| Leslie Robinson, MD | Chico |
| Sherry Taylor, MD | Fairfield |
Directors — Southern CA
| Garni Barkhoudarian, MD | Santa Monica |
| Linda Liau, MD | Los Angeles |
| Ian Ross, MD | Pasadena |
| N. Nicole Moayeri, MD | Santa Barbara |
Resident Board Consultants
| James Brazdzionis, DO | RUHS |
| Jessica Campos, MD | UCI |
| Jose Castillo, MD | UCD |
| Alex Lopez, MD | UCI |
Executive Secretary
| Emily Schile | Sacramento | emily@cans1.org |